Literature DB >> 8275227

In vitro and in vivo analysis of a rat bipotential O-2A progenitor cell line containing the temperature-sensitive mutant gene of the SV40 large T antigen.

S C Barnett1, R J Franklin, W F Blakemore.   

Abstract

Primary cultures from neonatal optic nerve contain pluripotential O-2A progenitor cells that are capable of differentiating into oligodendrocytes, type-2 astrocytes or adult O-2A progenitors (O-2Aadult). Since primary optic nerve cultures contain a mixture of glial cell types of which only a small number are O-2A progenitors, experiments on cell lineage and differentiation carried out using these cultures are both intrinsically limited and difficult to interpret. Ideally, cells from a clonal cell population would provide the optimal starting material for biological studies. In this paper we describe the creation of an O-2A progenitor cell line using a retrovirus carrying a temperature-sensitive mutant SV40 large T antigen gene. This cell line has provided sufficient numbers of cells to allow analysis of their in vitro properties and their behaviour following transplantation into an in vivo environment. At the non-permissive temperature (39 degrees C), these cells differentiate into oligodendrocytes and type-2 astrocytes in a similar fashion to O-2A progenitor cells from primary cultures (O-2Aprim). When grown in media containing platelet-derived growth factor and basic fibroblast growth factor, the cell numbers can be expanded in culture without differentiating, consistent with the behaviour of O-2Aprim progenitor cells. By exploiting this property, it has been possible to culture large numbers of O-2A progenitors for in vivo analysis. In this study we have shown that transplantation of this O-2A cell line into glia-free areas in adult rat spinal cord results in differentiation of a proportion of cells into oligodendrocytes which are capable of myelinating axons. Furthermore, differentiation of O-2A cells into astrocytes was also observed, indicating that the bipotentiality of these cells in vitro can also be demonstrated in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8275227     DOI: 10.1111/j.1460-9568.1993.tb00910.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  11 in total

Review 1.  Cell therapy in demyelinating diseases.

Authors:  Claire Rice; Christopher Halfpenny; Neil Scolding
Journal:  NeuroRx       Date:  2004-10

Review 2.  Strategies for achieving and monitoring myelin repair.

Authors:  Claire Rice; Neil Scolding
Journal:  J Neurol       Date:  2007-03-07       Impact factor: 4.849

Review 3.  Physiological relevance and functional potential of central nervous system-derived cell lines.

Authors:  S R Whittemore; E Y Snyder
Journal:  Mol Neurobiol       Date:  1996-02       Impact factor: 5.590

Review 4.  Glial lineages and myelination in the central nervous system.

Authors:  A Compston; J Zajicek; J Sussman; A Webb; G Hall; D Muir; C Shaw; A Wood; N Scolding
Journal:  J Anat       Date:  1997-02       Impact factor: 2.610

Review 5.  Transplanting oligodendrocyte progenitors into the adult CNS.

Authors:  R J Franklin; W F Blakemore
Journal:  J Anat       Date:  1997-01       Impact factor: 2.610

Review 6.  Glial ontogeny and glial neoplasia: the search for closure.

Authors:  M E Linskey
Journal:  J Neurooncol       Date:  1997-08       Impact factor: 4.130

Review 7.  Therapeutic strategies in multiple sclerosis. II. Long-term repair.

Authors:  N Scolding
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-10-29       Impact factor: 6.237

Review 8.  Repair of demyelinated lesions by glial cell transplantation.

Authors:  W F Blakemore; R J Franklin; A J Crang
Journal:  J Neurol       Date:  1994-12       Impact factor: 4.849

Review 9.  Olfactory ensheathing cells (OECs) and the treatment of CNS injury: advantages and possible caveats.

Authors:  Susan C Barnett; John S Riddell
Journal:  J Anat       Date:  2004-01       Impact factor: 2.610

Review 10.  Brain repair.

Authors:  A Compston
Journal:  J R Coll Physicians Lond       Date:  1994 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.